Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma
NCT04503460Phase 4Unknown
- Sponsor
- Imperial College London
- Start
- Jul 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol in asthma, sponsored by Imperial College London. Status: unknown.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04503460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04503460.